Get started
Author

Jordan B. Sparks

Observed names: Jordan B Sparks, Jordan Sparks, Sparks, Jordan B.
Observed institutions: Duke University, Veterans Health Administration, Health Services Research & Development, VA Ann Arbor Healthcare System, VA Center for Clinical Management Research, Ann Arbor VA Medical Center
ORCID: 0000-0002-1289-5476
Observed ORCID: 0000-0002-1289-5476
OpenAlex ID: A5030843592
The Consolidated Framework for Implementation Research (CFIR): progress to date, tools and resources, and plans for the future
2015 · Laura Damschroder, Carmen Hall, et al. · Implementation Science · 131
PDF
Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA)
2017 · Laura J. Damschroder, Caitlin M. Reardon, et al. · Implementation Science · 86
PDF
A Coaching by Telephone Intervention on Engaging Patients to Address Modifiable Cardiovascular Risk Factors: a Randomized Controlled Trial
2018 · Eugene Z. Oddone, Jennifer M. Gierisch, et al. · Journal of General Internal Medicine · 36
PDF
Planning and Reporting Effective Web-Based RAND/UCLA Appropriateness Method Panels: Literature Review and Preliminary Recommendations
2022 · Jordan B Sparks, Mandi L Klamerus, et al. · Journal of Medical Internet Research · 34
PDF
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)
2018 · Ted A. Skolarus, Sarah T. Hawley, et al. · Implementation Science · 27
PDF
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer
2023 · Kristian D. Stensland, Megan E.V. Caram, et al. · Urology · 23
PDF
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system
2023 · Daniel J. Herr, David A. Elliott, et al. · Cancer · 22
PDF
Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer
2021 · Ted A. Skolarus, Jane Forman, et al. · Implementation Science Communications · 17
PDF
Recurrence, metastasis, and survival after radical prostatectomy in the era of advanced treatments.
2022 · Kristian D. Stensland, Megan Veresh Caram, et al. · Journal of Clinical Oncology · 16
Applying User-Centered Design to Develop Practical Strategies that Address Overuse in Primary Care
2021 · Tanner J. Caverly, Sarah E. Skurla, et al. · Journal of General Internal Medicine · 13
PDF
Factors influencing treatment of veterans with advanced prostate cancer
2021 · Megan E. V. Caram, Jennifer Burns, et al. · Cancer · 10
PDF
Developing Strategies to Reduce Unnecessary Services in Primary Care: Protocol for User-Centered Design Charrettes
2019 · Mandi L Klamerus, Laura J Damschroder, et al. · JMIR Research Protocols · 9
PDF
A Coaching by Telephone Intervention for Veterans and Care Team Engagement (ACTIVATE): A study protocol for a Hybrid Type I effectiveness-implementation randomized controlled trial
2017 · Eugene Z. Oddone, Laura J. Damschroder, et al. · Contemporary Clinical Trials · 5
PDF
Survival by first‐line therapy and prognostic group among men with metastatic castration‐resistant prostate cancer
2024 · Megan E. V. Caram, Kyle Kumbier, et al. · Cancer Medicine · 3
Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies
2024 · Ted A. Skolarus, Sarah T. Hawley, et al. · Implementation Science Communications · 3
PDF
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System
2023 · Charles B. Nguyen, Christopher Kobe, et al. · JCO Oncology Practice · 2
PDF
Mental health care utilization among men with castration‐resistant prostate cancer receiving abiraterone or enzalutamide
2023 · Phoebe A. Tsao, Jennifer Burns, et al. · Cancer Medicine · 1
PDF
Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system
2023 · Megan E. V. Caram, Kyle Kumbier, et al. · Cancer Medicine · 1
The changing landscape of treatment and survival for men with castration-resistant prostate cancer in the era of novel treatments.
2022 · Megan Veresh Caram, Kyle Kumbier, et al. · Journal of Clinical Oncology · 1
Bone modifying agents in veterans with castration-resistant prostate cancer.
2021 · Jordan Bauman, Kyle Kumbier, et al. · Journal of Clinical Oncology · 1
Learning From the 'Tail End' of De-implementation: The Case of Chemical Castration for Localized Prostate Cancer
2020 · Ted A. Skolarus, Jane Forman, et al. · Research Square · 1
PDF
Progression to Castration Resistance and Metastatic Disease Following Androgen Deprivation Therapy for Biochemical Recurrence after Prostate Cancer Surgery
2026 · Gregory J. Raster, David A. Elliott, et al. · Cancer Epidemiology Biomarkers & Prevention
Hospice utilization in Veterans with newly diagnosed metastatic prostate cancer.
2025 · Jennifer Mei Lee, Kyle E. Kumbier, et al. · Journal of Clinical Oncology
Treatment intensification in veterans with metastatic prostate cancer.
2025 · Megan Veresh Caram, Phoebe A. Tsao, et al. · Journal of Clinical Oncology
PDF
Pd16-07 Assessing Causes of Death Among Men With Recurrent Prostate Cancer
2025 · Samuel Tremblay, Ted A. Skolarus, et al. · The Journal of Urology
PDF
Works count: 43
Citation count: 442
H-index: 10
I10-index: 11
Year
Topic
Type